These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11222463)

  • 21. Inhibition of thioredoxin-interacting protein may enhance the therapeutic effect of dehydrocostus lactone in cardiomyocytes under doxorubicin stimulation via the inhibition of the inflammatory response.
    Zhang X; Chu C; Huang Y
    Exp Ther Med; 2022 Mar; 23(3):226. PubMed ID: 35222703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature.
    Grillo TG; Almeida LR; Beraldo RF; Marcondes MB; Queiróz DAR; da Silva DL; Quera R; Baima JP; Saad-Hossne R; Sassaki LY
    World J Clin Cases; 2021 Nov; 9(33):10382-10391. PubMed ID: 34904114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice.
    Patel S; Kumthekar A
    Rheumatol Ther; 2022 Feb; 9(1):49-71. PubMed ID: 34797530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets.
    Reina-Couto M; Pereira-Terra P; Quelhas-Santos J; Silva-Pereira C; Albino-Teixeira A; Sousa T
    Front Physiol; 2021; 12():746494. PubMed ID: 34707513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship Between the Eosinophil/Monocyte Ratio and Prognosis in Decompensated Heart Failure: A Retrospective Study.
    Chen X; Huang W; Zhao L; Li Y; Wang L; Mo F; Guo W
    J Inflamm Res; 2021; 14():4687-4696. PubMed ID: 34557013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune-based therapies in cardiovascular and metabolic diseases: past, present and future.
    Murphy AJ; Febbraio MA
    Nat Rev Immunol; 2021 Oct; 21(10):669-679. PubMed ID: 34285393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Psoriasis Decision Tree.
    Monks G; Rivera-Oyola R; Lebwohl M
    J Clin Aesthet Dermatol; 2021 Apr; 14(4):14-22. PubMed ID: 34055182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Genetic Pathways Underlying Immunotherapy in Dilated Cardiomyopathy.
    Kadhi A; Mohammed F; Nemer G
    Front Cardiovasc Med; 2021; 8():613295. PubMed ID: 33937353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus.
    Dunmore BJ; Jones RJ; Toshner MR; Upton PD; Morrell NW
    Cardiovasc Res; 2021 Sep; 117(11):2309-2325. PubMed ID: 33399862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complexity of TNF-α Signaling in Heart Disease.
    Rolski F; Błyszczuk P
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33053859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Dynamic Interplay Between Cardiac Inflammation and Fibrosis.
    Thomas TP; Grisanti LA
    Front Physiol; 2020; 11():529075. PubMed ID: 33041853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein reduction with sacubitril-valsartan treatment in heart failure patients.
    Valentim Goncalves A; Pereira-da-Silva T; Galrinho A; Rio P; Moura Branco L; Soares R; Ilhao Moreira R; Cruz Ferreira R
    Am J Cardiovasc Dis; 2020; 10(3):174-181. PubMed ID: 32923098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T Cells Beyond Autoimmunity: From Pregnancy to Cancer and Cardiovascular Disease.
    Martini E; Giugliano S; Rescigno M; Kallikourdis M
    Front Immunol; 2020; 11():509. PubMed ID: 32296427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature.
    Bajaj NS; Gupta K; Gharpure N; Pate M; Chopra L; Kalra R; Prabhu SD
    ESC Heart Fail; 2020 Jun; 7(3):1319-1330. PubMed ID: 32198851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure.
    Yura Y; Sano S; Walsh K
    JACC Basic Transl Sci; 2020 Feb; 5(2):196-207. PubMed ID: 32140625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF-alpha inhibition for the treatment of cardiac sarcoidosis.
    Baker MC; Sheth K; Witteles R; Genovese MC; Shoor S; Simard JF
    Semin Arthritis Rheum; 2020 Jun; 50(3):546-552. PubMed ID: 31806154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodality Imaging of Inflammation and Ventricular Remodeling in Pressure-Overload Heart Failure.
    Glasenapp A; Derlin K; Wang Y; Bankstahl M; Meier M; Wollert KC; Bengel FM; Thackeray JT
    J Nucl Med; 2020 Apr; 61(4):590-596. PubMed ID: 31653713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurohormones, inflammatory mediators, and cardiovascular injury in the setting of heart failure.
    Grosman-Rimon L; Billia F; Wright E; Carasso S; Elbaz-Greener G; Kachel E; Rao V; Cherney D
    Heart Fail Rev; 2020 Sep; 25(5):685-701. PubMed ID: 31637568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers in heart failure: the past, current and future.
    Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F
    Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure.
    Matsumoto H; Kasai T; Sato A; Ishiwata S; Yatsu S; Shitara J; Murata A; Kato T; Suda S; Matsue Y; Hiki M; Takagi A; Daida H
    Heart Vessels; 2019 Dec; 34(12):1961-1968. PubMed ID: 31104078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.